Skip to main content
  • Forums
  • Log in
  • Contact us
  • Policy
www.notifylibrary.org
  • The Notify Project
    • History
    • Who we are
    • Interviews
        1. Health authorities
        2. The Experts
    • Useful links
    • Global consultation reports
  • Search Library
    • Search tutorial
    • Adverse occurrence search
    • Reference search
    • Bibliographic list
        1. Authors
        2. Keywords
    • Add or update record
    • Editorial Group Tools
        1. MPHO taxonomy
        2. Adv. occurrence taxonomy
        3. Imputability table
        4. VIDEO TUTORIAL
    • Database content analysis
  • Notify Booklet
    • 1 INTRODUCTION
    • 2 THE V&S CHAIN FOR MPHOs
    • 3 VIGILANCE AND SURVEILLANCE: HISTORY AND BASIC ELEMENTS
    • 4 MEDICAL PRODUCTS OF HUMAN ORIGIN (MPHO) - DONATION AND ETHICS
    • ANNEX 1. Notify Library - MPHO type taxonomy
    • 5 TOWARDS A GLOBAL GOVERNANCE OF MPHO
    • 6 THE V&S SYSTEM IS PRIMARILY A RESPONSIBILITY FOR HEALTH AUTHORITIES
    • 7 ORGANIZATION FOR A COMPREHENSIVE - VIGILANCE & SURVEILLANCE SYSTEM
    • 8 VIGILANCE & SURVEILLANCE - RECOGNITION RELIES ON HEALTH CARE STAFF
    • 9 INVESTIGATING OCCURRENCES THAT COULD CAUSE HARM - LEARNING FROM ERRORS
    • 10 PROJECT NOTIFY
    • 11 THE NOTIFY DATABASE - LEARNING FROM VIGILANCE
    • 12 RISKS ASSOCIATED WITH LIVING DONATION
    • 13 HARM TO RECIPIENT - INFECTIONS
    • 14 HARM TO RECIPIENT - NON INFECTIOUS BLOOD TRANSFUSION REACTIONS
    • 15 HARM TO RECIPIENTS - MALIGNANCY
    • 16 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - HPC
    • 17 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - gamets and embryos
    • 18 CHARACTERISTICS, HANDLING AND CLINICAL ERRORS
    • 19 TRACEABILITY, AN ABSOLUTE PRE-REQUISITE FOR MPHO SAFETY
    • ANNEX 2. Notify Library - Adverse occurrence type taxonomy
    • REFERENCES
  • Background Documents
Home / Bibliography

Bibliography

Export 8 results:
Filters: Author is Cavanagh,H. D.  [Clear All Filters]
2006
Sanchez P, Heck E, Rivera C, Sanchez A, Cavanagh HD. Risk factors for infectious disease in corneal transplant screening. Eye Contact Lens. 2006;32(3):124-7.
2003
Hogan RN, Cavanagh HD, Brown P. Qualifications to the report of a new case of Creutzfeldt-Jakob disease in the recipient of a corneal transplant. Arch Neurol. 2003;60(2):293-4; - author - reply - 294.
1999
Hogan RN, Brown P, Heck E, Cavanagh HD. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18(1):2-11.
1998
Nartey IN, Cavanagh HD, Jester JV, Andrews P, Petroll WM. Characterization of specular "dark events" in human donor corneal endothelium by scanning and transmission electron microscopy. Cornea. 1998;17(5):544-9.
1995
Cavanagh HD. Eye banking 1995: danger and opportunity. Cornea. 1995;14(6):545-6.
Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea. 1995;14(6):547-53.
1985
Insler MS, Cavanagh HD, Wilson LA. Gentamicin-resistant Pseudomonas endophthalmitis after penetrating keratoplasty. BrJOphthalmol. 1985;69(3):8.
1983
Leveille AS, McMullan FD, Cavanagh HD. Endophthalmitis following penetrating keratoplasty. Ophthalmology. 1983;90(1):38-9.
↑
  • Forums
  • Log in
  • Contact us
  • Policy

Disclaimer

The cases, bibliography and associated comments included in this website and database have been provided by experts worldwide and reviewed by voluntary editorial working groups. The data and information is not guaranteed to be complete or to be fully up to date at any particular moment and it reflects the knowledge and views of the experts participating, not those of the World Health Organisation or the Italian National Transplant Centre.